Phase III clinical trial - Gynécologie - Col utérus
SENTICOL III
Gynécologie - Col utérus
Ouvert depuis le: 07.27.2024
Site: Paris
Ouvert depuis le: 11.26.2019
Site: Saint-Cloud
Public cible
Adulte
International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer
Description de l'essai
SENTICOL III is large prospective multicenter international randomized study designed to validate the Sentinel Lymph Node (SLN) mapping technique in early cervical cancer. This "validation study" will compare the outcome of patients with negative SLN (experimental arm) vs patients with negative SLN + Pelvic Lymph Node dissection (PLN)(reference arm).
Liens utiles
![VIRGINIE FOURCHOTTE Vignette](/sites/default/files/styles/carre_petit/public/annuaire/00002025-612fa6b3ea5d2.jpg?h=04d92ac6&itok=KJH-DPXP)
VIRGINIE FOURCHOTTE
Investigateur principal
![VIRGINIE FOURCHOTTE Vignette](/sites/default/files/styles/carre_petit/public/annuaire/00002025-612fa6b3ea5d2.jpg?h=04d92ac6&itok=KJH-DPXP)
VIRGINIE FOURCHOTTE
Investigateur principal